Travel & financial grants

Johnson & Johnson

The provided page content is a raw PDF stream and cannot be parsed to extract information about the grant's coverage or eligibility requirements. Therefore, details about what the grant covers and who qualifies are unknown.

Johnson & Johnson

Sobi

Kineret ON TRACK® is a patient support program that assists individuals prescribed KINERET medication by offering information on insurance coverage and financial assistance options. It encompasses a copay assistance program for commercially insured patients, covering up to $13,000 annually, and various patient assistance programs providing KINERET at no cost for eligible patients facing coverage delays or gaps. This program focuses solely on medication costs and does not provide travel assistance.

Leukemia & Lymphoma Society

HealthWell Foundation

This grant from the HealthWell Foundation provides financial assistance for prescription drug copays or Medicare Part B insurance premiums for patients being treated for Multiple Myeloma. To qualify, applicants must have Medicare (Part B for premium assistance), be receiving treatment in the United States, and have a household income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living areas.

National Kidney Foundation of Florida

Due to the unreadable nature of the provided page content, it is not possible to determine the specific coverage types or eligibility requirements for the National Kidney Foundation of Florida Patient Assistance Program. Further information is needed to describe what the grant covers and who qualifies.

Information about the Nexavar and Stivarga REACH Program could not be found in the provided page content. The page lists various patient assistance programs but does not mention this specific grant.

Information about the Nexavar and Stivarga REACH Program could not be found on the provided page content. Therefore, specific details regarding its coverage, eligibility, and application process are unknown.

Novartis Pharmaceuticals Corporation

The Novartis Patient Support (COSENTYX Connect) program offers co-pay assistance for privately insured patients taking COSENTYX, aiming for $0 out-of-pocket costs if eligible. It also provides free medication for up to two years for eligible privately insured patients whose initial coverage is denied, while working to secure insurance approval. Eligibility excludes patients covered by federal or state programs like Medicare or Medicaid.

HealthWell Foundation

This grant from HealthWell Foundation provides assistance with prescription drug copays or Medicare Part B insurance premiums for patients receiving treatment for ovarian cancer in the United States. Eligible applicants must have Medicare and an income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living. The fund is currently closed to new patients due to lack of sufficient funding.

HealthWell Foundation

This HealthWell Foundation grant, currently closed to new patients, offers financial assistance for prescription drug copays or Medicare Part B insurance premiums for individuals with Ovarian Cancer. Eligible applicants must be receiving treatment in the U.S., have Medicare, and have a household income up to 500% of the Federal Poverty Level, adjusted for household size and high cost of living.

PAN Foundation

Patient Access Network Foundation

The PAN: Sickle Cell Disease (Medicare) program offers up to a $2000 annual benefit for medications to patients with sickle cell disease who have Medicare/Medicaid and reside in the US or Puerto Rico. It is a needs-based program, but it is currently not funded.

Pfizer

The Pfizer enCompass Co-Pay Assistance Program helps commercially insured patients reduce their out-of-pocket costs for ABRILADA treatment, offering a co-pay as low as $0, with an annual maximum benefit ranging from $4,000 to $14,000. Additionally, eligible patients may receive a Sharps Container and Travel Kit. The program is not available for patients with state or federally funded insurance or cash-paying patients.

PAN Foundation

The PAN Foundation Transportation Fund offered grants of $500 to cover transportation expenses such as gas, parking, public transportation, taxis, and airfare. This fund is currently closed, and no specific eligibility requirements are detailed on this resource page.

Spondylitis Association of America

The Spondylitis Association of America hosts a resource page that lists various prescription assistance programs offered by pharmaceutical companies. These programs primarily help with the costs of medications, co-pays, and other healthcare needs for individuals with spondyloarthritis. This page does not provide information about patient travel assistance grants.

Spondylitis Association of America

This page serves as a directory of patient assistance programs from various pharmaceutical companies, specifically aimed at helping individuals with spondyloarthritis manage prescription medication costs, co-pays, and other healthcare expenses. Eligibility criteria, often tied to financial need and insurance status, are determined by each individual program. This resource does not provide direct financial grants for travel assistance.

The Assistance Fund

The Assistance Fund: Thyroid Cancer program aims to support US and Puerto Rico residents with thyroid cancer, covering copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses for FDA-approved treatments, and potentially off-label drugs. Eligibility requires commercial insurance, Medicare, or Medicaid, based on financial need. However, the program is currently not funded.

The Assistance Fund

The Assistance Fund: Thyroid Cancer program helps manage copays, coinsurance, and deductibles for FDA-approved thyroid cancer treatments, along with other eligible out-of-pocket costs such as health insurance premiums and incidental medical expenses. It is available for commercially insured or Medicare/Medicaid patients with thyroid cancer who reside in the US and Puerto Rico. Eligibility is needs-based, requiring verification of financial and demographic information.

Neuroendocrine Cancer Foundation

The CureNET Project offers a $5,000 grant to any NET patient 18 years or older. Funds can be used to cover medical costs, travel to see a NET specialist, pay bills, and allow families to spend time together, with the recipient deciding the necessary use.

Information regarding the Tyvaso Patient Assistance Program could not be found within the provided page content. Therefore, specific details about its coverage, eligibility, or application process cannot be extracted from this source.

HealthWell Foundation

The HealthWell Foundation's Urea Cycle Disorders fund offers financial assistance for prescription drug copays or Medicare Part B insurance premiums. To qualify, applicants must be treated for Urea Cycle Disorders in the United States, have health insurance (Medicare Part B for premium assistance), and meet an income limit up to 500% of the Federal Poverty Level. This fund is currently closed to new patients.

HealthWell Foundation

Information regarding the VELCADE Patient Assistance Program could not be found within the provided page content. The page lists various other patient assistance programs, but VELCADE is not among them in the extracted text.

Information specific to the "Xofigo Access Services" grant, including its coverage, eligibility, and sponsoring organization, could not be found within the provided page content. The page lists various prescription assistance programs but does not mention this specific grant.